Assaying of digoxin by means of bioluminescence and inhibition of NA.sup.+-.sup.+ -ATPase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 28, 1981
Grant Date -
N/A
app pub date -
Jul 24, 1979
filing date -
Jul 26, 1978
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method is described for quantitative measurement of digoxin and other digitaloids in serum. The method is based on the inhibition of Na.sup.+, K.sup.+ --specific ATPase enzyme by digitaloids as a result of receptor binding principle and the measurement of this inhibition with the firefly luceferin--luciferase bioluminescence assay of APT. Method is specific and has similar sensitivity to that of the commonly used radioimmunoassay, but simpler and can be performed with low-cost instrumentation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully